Magnum Experiment 97C

Asset Allocation

Position	Category/Sector	Target Weight
AVGO Broadcom Inc.	Technology	13.76%
LLY Eli Lilly and Company	Healthcare	32.10%
MCD McDonald's Corporation	Consumer Cyclical	7.15%
MRK Merck & Co., Inc.	Healthcare	11.74%
MSFT Microsoft Corporation	Technology	11.33%
NVDA NVIDIA Corporation	Technology	9.08%
UNH UnitedHealth Group Incorporated	Healthcare	14.83%

Benchmark Against

Benchmark

S&P 500 Index

Rebalance

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Magnum Experiment 97C, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Loading graphics...

The earliest data available for this chart is Aug 6, 2009, corresponding to the inception date of AVGO

Returns By Period

As of Apr 11, 2026, the Magnum Experiment 97C returned -4.29% Year-To-Date and 31.45% of annualized return in the last 10 years.

	1D	1M	YTD	6M	1Y	3Y*	5Y*	10Y*
Benchmark S&P 500 Index	-0.11%	2.16%	-0.42%	4.03%	27.10%	18.38%	10.55%	12.70%
Portfolio Magnum Experiment 97C	0.04%	1.77%	-4.29%	7.92%	29.19%	33.88%	32.53%	31.45%
Portfolio components:
AVGO Broadcom Inc.	4.69%	10.82%	7.58%	14.91%	105.87%	83.91%	53.30%	40.88%
LLY Eli Lilly and Company	-1.65%	-3.87%	-12.44%	13.07%	29.22%	38.18%	39.87%	31.00%
MCD McDonald's Corporation	-1.25%	-5.63%	0.58%	4.12%	0.92%	4.81%	8.15%	11.80%
MRK Merck & Co., Inc.	-1.03%	5.53%	16.21%	43.46%	58.92%	5.77%	14.31%	12.08%
MSFT Microsoft Corporation	-0.59%	-7.71%	-23.14%	-27.12%	-3.79%	10.31%	8.60%	22.66%
NVDA NVIDIA Corporation	2.57%	3.00%	1.15%	3.00%	70.08%	90.83%	67.37%	71.10%
UNH UnitedHealth Group Incorporated	-0.84%	9.85%	-7.09%	-12.90%	-47.80%	-14.75%	-2.50%	10.95%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Aug 7, 2009, Magnum Experiment 97C's average daily return is +0.11%, while the average monthly return is +2.16%. At this rate, an investment would double in approximately 2.7 years.

Historically, 71% of months were positive and 29% were negative. The best month was Oct 2021 with a return of +13.6%, while the worst month was Jan 2022 at -8.0%. The longest winning streak lasted 13 consecutive months, and the longest losing streak was 3 months.

On a daily basis, Magnum Experiment 97C closed higher 55% of trading days. The best single day was Mar 13, 2020 with a return of +9.3%, while the worst single day was Mar 16, 2020 at -12.8%.

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Total
2026	-3.90%	0.93%	-7.02%	6.11%									-4.29%
2025	0.86%	0.92%	-6.04%	1.87%	-2.39%	7.65%	-1.69%	3.29%	5.68%	6.70%	10.64%	-1.59%	27.64%
2024	7.85%	10.61%	3.72%	-2.17%	4.78%	8.81%	-3.39%	7.72%	-1.19%	-4.01%	0.26%	1.73%	38.94%
2023	1.04%	-0.99%	9.19%	7.33%	9.64%	6.68%	0.10%	6.65%	-3.99%	2.27%	7.35%	3.45%	59.65%
2022	-7.97%	-0.81%	9.31%	-4.07%	3.30%	-2.23%	5.84%	-7.42%	-3.07%	10.47%	7.50%	-2.67%	6.13%
2021	6.65%	0.01%	-0.46%	2.07%	4.91%	8.90%	3.22%	4.36%	-6.05%	13.55%	0.25%	8.18%	54.31%

Benchmark Metrics

Magnum Experiment 97C has an annualized alpha of 15.93%, beta of 0.91, and R² of 0.69 versus S&P 500 Index. Calculated based on daily prices since August 07, 2009.

This portfolio captured 123.77% of S&P 500 Index gains but only 47.16% of its losses — a favorable profile for investors.
This portfolio generated an annualized alpha of 15.93% versus S&P 500 Index — delivering returns beyond what market exposure alone would predict.
With beta of 0.91 and R² of 0.69, this portfolio moves broadly in line with S&P 500 Index — much of its variation is explained by market exposure rather than independent behavior.

Alpha: 15.93%

Beta: 0.91

R²: 0.69

Upside Capture: 123.77%

Downside Capture: 47.16%

Expense Ratio

Magnum Experiment 97C has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

The portfolio doesn't include any funds that charge management fees.

Return for Risk

Risk / Return Rank

Magnum Experiment 97C ranks 17 for risk / return — in the bottom 17% of portfolios on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

Overall Rank

Sharpe Ratio Rank

Sortino Ratio Rank

Omega Ratio Rank

Calmar Ratio Rank

Martin Ratio Rank

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

	Portfolio	Benchmark	Difference
Sharpe ratio Return per unit of total volatility	1.65	2.23	-0.58
Sortino ratio Return per unit of downside risk	2.31	3.12	-0.81
Omega ratio Gain probability vs. loss probability	1.30	1.42	-0.12
Calmar ratio Return relative to maximum drawdown	2.51	4.05	-1.54
Martin ratio Return relative to average drawdown	8.43	17.91	-9.48
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.

	Risk / Return Rank	Sharpe ratio	Sortino ratio	Omega ratio	Calmar ratio	Martin ratio
AVGO Broadcom Inc.	86	2.76	3.36	1.43	4.89	11.77
LLY Eli Lilly and Company	51	0.76	1.26	1.18	1.00	2.43
MCD McDonald's Corporation	34	0.12	0.30	1.03	0.41	0.91
MRK Merck & Co., Inc.	83	2.27	3.11	1.39	4.31	12.28
MSFT Microsoft Corporation	29	-0.08	0.05	1.01	0.16	0.40
NVDA NVIDIA Corporation	81	2.19	2.75	1.34	4.75	11.78
UNH UnitedHealth Group Incorporated	8	-0.93	-1.17	0.81	-0.72	-0.94

Sharpe Ratio

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Magnum Experiment 97C Sharpe ratios as of Apr 11, 2026 (values are recalculated daily):

1-Year: 1.65
5-Year: 1.68
10-Year: 1.56
All Time: 1.49

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 2.14 to 3.05, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests weaker risk-adjusted returns than most portfolios, possibly due to lower returns, higher volatility, or both. It may be worth reviewing the allocation. You can use the Portfolio Optimization tool to explore options for improving the Sharpe ratio.

The chart below shows the rolling Sharpe ratio of Magnum Experiment 97C compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

Loading graphics...

Dividends

Dividend yield

Magnum Experiment 97C provided a 1.33% dividend yield over the last twelve months.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Portfolio	1.33%	1.28%	1.21%	1.25%	1.52%	1.49%	1.83%	1.95%	1.97%	2.03%	2.20%	2.14%
Portfolio components:
AVGO Broadcom Inc.	0.67%	0.70%	0.94%	1.71%	3.02%	2.24%	3.05%	3.54%	3.11%	1.87%	1.43%	1.13%
LLY Eli Lilly and Company	0.66%	0.56%	0.67%	0.78%	1.07%	1.23%	1.75%	1.96%	1.94%	2.46%	2.77%	2.37%
MCD McDonald's Corporation	2.38%	2.35%	2.34%	2.10%	2.15%	1.96%	2.35%	2.39%	2.36%	2.23%	2.97%	2.91%
MRK Merck & Co., Inc.	2.73%	3.12%	3.14%	2.72%	2.52%	3.41%	3.03%	2.48%	2.60%	3.36%	3.14%	3.43%
MSFT Microsoft Corporation	0.94%	0.70%	0.73%	0.74%	1.06%	0.68%	0.94%	1.20%	1.69%	1.86%	2.37%	2.33%
NVDA NVIDIA Corporation	0.02%	0.02%	0.03%	0.03%	0.11%	0.05%	0.12%	0.27%	0.46%	0.29%	0.45%	1.20%
UNH UnitedHealth Group Incorporated	2.90%	2.64%	1.62%	1.38%	1.21%	1.12%	1.38%	1.41%	1.38%	1.30%	1.48%	1.59%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Magnum Experiment 97C. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Magnum Experiment 97C was 26.41%, occurring on Mar 23, 2020. Recovery took 24 trading sessions.

The current Magnum Experiment 97C drawdown is 6.62%.

Depth	Start	To Bottom	Bottom	To Recover	End	Total
-26.41%	Feb 20, 2020	23	Mar 23, 2020	24	Apr 27, 2020	47
-16.91%	Oct 15, 2024	118	Apr 4, 2025	106	Sep 8, 2025	224
-15.43%	Jul 25, 2011	11	Aug 8, 2011	96	Dec 22, 2011	107
-15.04%	Nov 28, 2025	83	Mar 30, 2026	—	—	—
-14.25%	Dec 30, 2015	30	Feb 11, 2016	42	Apr 13, 2016	72

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.

Loading graphics...

Diversification

Diversification Metrics

Number of Effective Assets

The portfolio contains 7 assets, with an effective number of assets of 5.44, reflecting the diversification based on asset allocation. This number of effective assets indicates a moderate level of diversification, where some assets may have a more significant influence on overall performance.

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

	Benchmark	MCD	MRK	UNH	LLY	NVDA	AVGO	MSFT	Portfolio
Benchmark	1.00	0.47	0.42	0.47	0.44	0.61	0.61	0.71	0.76
MCD	0.47	1.00	0.34	0.32	0.26	0.21	0.25	0.34	0.42
MRK	0.42	0.34	1.00	0.35	0.48	0.13	0.17	0.26	0.52
UNH	0.47	0.32	0.35	1.00	0.33	0.22	0.24	0.30	0.55
LLY	0.44	0.26	0.48	0.33	1.00	0.23	0.24	0.32	0.73
NVDA	0.61	0.21	0.13	0.22	0.23	1.00	0.56	0.54	0.62
AVGO	0.61	0.25	0.17	0.24	0.24	0.56	1.00	0.49	0.65
MSFT	0.71	0.34	0.26	0.30	0.32	0.54	0.49	1.00	0.64
Portfolio	0.76	0.42	0.52	0.55	0.73	0.62	0.65	0.64	1.00

The correlation results are calculated based on daily price changes starting from Aug 7, 2009

Magnum Experiment 97C

Asset Allocation

Performance

Performance Chart

Returns By Period

Monthly Returns

Benchmark Metrics

Expense Ratio

Return for Risk

Risk / Return Rank

Return / Risk — by metrics

Sharpe ratio

Sortino ratio

Omega ratio

Calmar ratio

Martin ratio

Sharpe Ratio

Dividends

Dividend yield

Drawdowns

Drawdowns Chart

Worst Drawdowns

Volatility

Volatility Chart

Diversification

Diversification Metrics

Number of Effective Assets

Asset Correlations Table